Physician profile
Karen E Dickes
NPI 1487851754
$1,891.40
in general payments reported to CMS, 2019-2025
21 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2021: $223 · 2022: $374 · 2023: $475 · 2024: $272 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $506.25 | 2022-2023 | |
| Alcon Vision LLC | $330.45 | 2019-2025 | Clareon, Centurion, Rocklatan |
| Sight Sciences, INC. | $199.25 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Sun Pharmaceutical Industries INC. | $99.10 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $96.31 | 2019 | |
| Bausch & Lomb Americas INC. | $93.45 | 2022-2024 | Envista Mx60 Iol, Xiidra |
| Abbvie INC. | $88.21 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $69.40 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $63.52 | 2021 | |
| Astellas Pharma US INC | $57.20 | 2023-2024 | Izervay |
| Biotissue Holdings INC. | $53.97 | 2025 | |
| Amgen INC. | $37.48 | 2025 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $34.46 | 2024 | Healon Duet Pro |
| Coherus Oncology, INC. | $31.09 | 2023 | |
| Aerie Pharmaceuticals, INC. | $26.66 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $22.95 | 2021 | |
| Allergan, INC. | $22.88 | 2021 | |
| Apellis Pharmaceuticals, INC. | $20.07 | 2023 | Syfovre |
| Eyepoint US, INC. | $17.97 | 2023 | |
| Omeros Corporation | $13.15 | 2019 | |
| The Cameron-Ehlen Group, INC. | $7.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Dickes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.